Acutaas Chemicals Ltd

📈 Acutaas Chemicals Reports Strong Q4 FY26 Results & Future Outlook

- Q4 FY26 revenue: ₹4,328 million, up 40.3% year-over-year

- Q4 FY26 PAT: ₹1,343 million, up 114.1% year-over-year

- PAT margin in Q4 FY26: 31.0%

- Full-year FY26 revenue: ₹13,394 million, up 33.0% from FY25

- Full-year FY26 PAT: ₹3,564 million, up 122.2% year-over-year

- Gross margin in Q4 FY26: 62.0%, up from 47.3% in Q4 FY25

- EBITDA margin in Q4 FY26: 42.4%

- Company focuses on Battery Chemicals, Semiconductors, and Pharmaceutical CDMO

- Executive Chairman & Managing Director Naresh Patel projects 25% revenue growth for FY27